Members |
associationTargetComponent |
[X]Poisoning by and exposure to pesticides, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence at home, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence at industrial and construction area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence at other specified place, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence at school, other institution and public administrative area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence at sports and athletics area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence at trade and service area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence at unspecified place, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence in residential institution, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence on farm, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, occurrence on street and highway, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to psychotropic drugs, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence at home, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence at industrial and construction area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence at other specified place, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence at school, other institution and public administrative area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence at sports and athletics area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence at trade and service area, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence at unspecified place, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence in residential institution, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence on farm, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, occurrence on street and highway, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by and exposure to sedative hypnotics, undetermined intent |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by anaesthetic, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by antimalarials and drugs acting on other blood protozoa |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by antiparkinsonism drugs and other central muscle-tone depressants |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by drugs and biological substances |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by mixed antiepileptics, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other agents primarily affecting gastrointestinal system |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other analgesics, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified agents primarily affecting the cardiovascular system |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified antidepressants |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified antipsychotics and neuroleptics |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified antipsychotics and neuroleptics |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified autonomic nervous system drugs |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified drugs acting on muscles |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified drugs and biological substances |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified general anesthetics |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified hormone antagonists |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified hormones and synthetic substitutes |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified narcotics |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified psychodysleptics [hallucinogens] |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other and unspecified respiratory system drugs |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other antacids and anti-gastric-secretion drugs |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other antidysrhythmic drugs, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other antiepileptic and sedative-hypnotic drugs |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other antihypertensive drugs, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other antimycobacterial drugs |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other antiprotozoal drugs |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other estrogens and progestogens |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other laxatives, including intestinal atonia drugs |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other non-steroidal anti-inflammatory drugs [NSAID] |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other opioids |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other parasympathomimetics [cholinergics] |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other primarily systemic and hematological agents |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other psychotropic drugs, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other specified systemic anti-infectives and antiparasitics |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other synthetic narcotics |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other systemic antibiotics |
HSCIC (UK) Namespace 1000000 |
[X]Poisoning by other topical agents |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathies and other disorders of the peripheral nervous system |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy in infectious and parasitic diseases classified elsewhere |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy in neoplastic disease classified elsewhere |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy in nutritional deficiency classified elsewhere |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy in other diseases classified elsewhere |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy in other endocrine and metabolic diseases classified elsewhere |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy in other musculoskeletal disorders classified elsewhere |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy in systemic connective tissue disorders classified elsewhere |
HSCIC (UK) Namespace 1000000 |
[X]Polyneuropathy, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Polyp of female genital tract, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Polyp of female genital tract, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Polyp of other parts of female genital tract |
HSCIC (UK) Namespace 1000000 |
[X]Post-traumatic arthrosis of other joints |
HSCIC (UK) Namespace 1000000 |
[X]Post-traumatic hydrocephalus, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Post-traumatic hydrocephalus, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Post-traumatic wound infection, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Postprocedural disorder of eye and adnexa, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Postprocedural disorder of eye and adnexa, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Postprocedural endocrine and metabolic disorder, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Postprocedural endocrine and metabolic disorder, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Postprocedural musculoskeletal disorder, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Postprocedural musculoskeletal disorder, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Pre-existing diabetes mellitus, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Pre-existing diabetes mellitus, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Predominantly alpha-adrenoreceptor agonists causing adverse effects in therapeutic use, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Predominantly beta-adrenoreceptor agonists causing adverse effects in therapeutic use, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Predominantly compulsive acts [obsessional rituals] |
HSCIC (UK) Namespace 1000000 |
[X]Predominantly obsessional thoughts or ruminations |
HSCIC (UK) Namespace 1000000 |
[X]Preparatory care for subsequent treatment, not elsewhere classified |
HSCIC (UK) Namespace 1000000 |
[X]Presence of cardiac and vascular implant and graft, unspecified |
HSCIC (UK) Namespace 1000000 |
[X]Presence of other bone and tendon implants |
HSCIC (UK) Namespace 1000000 |
[X]Presence of other cardiac and vascular implants and grafts |
HSCIC (UK) Namespace 1000000 |
[X]Presence of other heart valve replacement |
HSCIC (UK) Namespace 1000000 |
[X]Presence of other specified devices |
HSCIC (UK) Namespace 1000000 |
[X]Presence of other specified functional implants |
HSCIC (UK) Namespace 1000000 |
[X]Presence of silicon implant in breast |
HSCIC (UK) Namespace 1000000 |
[X]Presence of silicon implant in breast |
HSCIC (UK) Namespace 1000000 |
[X]Primarily systemic agents causing adverse effects in therapeutic use |
HSCIC (UK) Namespace 1000000 |